SCHEMBL7980019

SCHEMBL7980019

Nc1nc2c(-c3c(F)cccc3Cl)cc(NCCCN3CCOCC3)cc2n2cncc12

nearest known ligand 0.52

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
LCK P06239 4/20 0.52
FGFR1 P11362 7/20 0.46
SRC P12931 3/20 0.46
FGFR2 P21802 1/20 0.44
FGFR4 P22455 1/20 0.44
FGFR3 P22607 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
KDR P35968 2/20 0.41
GSK3A P49840 2/20 0.40
GSK3B P49841 2/20 0.40
POLB P06746 2/20 0.40
MAPT P10636 1/20 0.40
MAP3K8 P41279 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7983616 0.95 LCK (0.51) LCKFGFR1SRCFGFR2FGFR4
SCHEMBL7983212 0.92 LCK (0.60) LCKFGFR1SRCFGFR2FGFR4
SCHEMBL7983677 0.91 FGFR1 (0.50) LCKFGFR1SRCFGFR2FGFR4
SCHEMBL7983651 0.87 LCK (0.59) LCKFGFR1SRCFGFR2FGFR4
SCHEMBL7987033 0.82 LCK (0.49) LCKFGFR1SRCL3MBTL1KDR
SCHEMBL7982995 0.82 LCK (0.47) LCKFGFR1SRCKDR
SCHEMBL7987540 0.81 LCK (0.46) LCKFGFR1SRCKDR
SCHEMBL7969619 0.81 LCK (0.37) LCK
SCHEMBL7979832 0.81 LCK (0.49) LCKFGFR1SRCFGFR2KDR
SCHEMBL7969694 0.80 LCK (0.38) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed